ISSN 1016-5169 | E-ISSN 1308-4488
The Dilemma of Edoxaban Interruption and Heparin Bridging Before Upgrading to Cardiac Resynchronization Therapy in an Older Patient with Atrial Fibrillation, Chronic Kidney Disease, and Mitral Bioprosthesis [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. Ahead of Print: TKDA-86907 | DOI: 10.5543/tkda.2024.86907

The Dilemma of Edoxaban Interruption and Heparin Bridging Before Upgrading to Cardiac Resynchronization Therapy in an Older Patient with Atrial Fibrillation, Chronic Kidney Disease, and Mitral Bioprosthesis

Mert Doğan, Uğur Canpolat
Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye

The peri-procedural management of novel oral anticoagulants (NOAC) should be individualized based on the patient (age, body weight, renal function, medications, previous thromboembolic/bleeding event, presence of prosthetic valve) and procedural (bleeding risk) characteristics. Less invasive procedures carry a relatively low bleeding risk and may be performed under minimally- or uninterrupted NOAC therapy. However, upgrading from implantable cardioverter defibrillator (ICD) to cardiac resynchronization therapy (CRT) is more complex than the initial implantation procedure. Thus, the timing of the last NOAC intake before an elective procedure requires judgment based on the individual benefit/risk ratio. Herein, we presented the management of an elderly patient with atrial fibrillation, grade IIIb chronic renal disease, low body weight, and bioprosthetic mitral valve who underwent upgrading from ICD to CRT-D procedure, experienced a bioprosthetic valve thrombosis 24 hours after an interruption of edoxaban therapy without heparin bridging, and successfully treated with ultraslow tPA therapy.

Keywords: Edoxaban, interruption, novel oral anticoagulant, thrombosis

Corresponding Author: Uğur Canpolat, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.